Cost-effectiveness of human papillomavirus vaccination in Germany

Table 5 Utility values

Health state	Utility value	Duration	Source
Treatment of CIN 1	0.91	2 months	[47]
Treatment of CIN 2	0.87	2 months	[47]
Treatment of CIN 3	0.87	2 months	[47]
Treatment of CIS	0.80	2 months	[48]
Follow-up of CIS	0.97	1.8 years (22 months)	[48]
Treatment of FIGO I	0.65	6 months	[87]
Follow-up of FIGO I	0.97	Up to 4.5 years (54 months)	[48, 87]
Treatment of FIGO II	0.56	6 months	[87]
Follow-up of FIGO II	0.90	Up to 4.5 years (54 months)	[48, 87]
Treatment of FIGO III	0.56	6 months	[87]
Follow-up of FIGO III	0.90	Up to 4.5 years (54 months)	[48, 87]
Treatment of FIGO IV	0.48	6 months	[88]
Follow-up of FIGO IV	0.62	Up to 4.5 years (54 months)	[48, 87]
Palliative care	0.29	1 month	[89]
Treatment of genital warts	0.93	2 months	[46, 48] (mean value of both sources)

CIN cervical intraepithelial neoplasia, CIS carcinoma in situ, FIGO International Federation of Gynecology and Obstetrics

ISSN: 1478-7547